The Laboratory of Hugh Auchincloss, MD, uses institutional data combined with large national and international databases to answer questions about the treatment and prognosis of lung cancer and other thoracic surgery diseases.
Research in the Colson Laboratory focuses on surgical innovation and surgical oncology, with NIH funding to study several novel approaches to cancer therapy with prior expertise in transplantation immunology and immune recognition.
The research of Henning Gaissert, MD, aims to change clinical practice for common and uncommon thoracic diseases to inform national and international audiences about them.
The Laboratory of Michael Lanuti, MD, leads translational research with the goal of designing novel therapeutics to treat lung and esophageal cancer to bring to clinical trials.
The research efforts of Christopher Morse, MD, are focused on improving the outcomes of the swallowing, heartburn and esophageal diseases that he treats at Massachusetts General Hospital.
The Laboratory of Douglas Mathisen, MD, at Massachusetts General Hospital performs clinical research focused on elucidating diseases of the airway and thoracic oncology.
The Laboratory of Uma Sachdeva, MD, PhD, at Massachusetts General Hospital uses 3D culture models of human and mouse-derived cells to study the pathogenesis of esophageal cancer.
Research led by Cameron Wright, MD, focuses on the surgical outcomes of the patients he treats at Massachusetts General Hospital.
The clinical and translational research of Chi-Fu Jeffrey Yang, MD, aims to improve care for patients with lung cancer and other diseases of the chest.
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.